Clinical Registry Describing Treatment Reality of Patients With Cancer-induced Anemia
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Anemia
Both
Anemia
Trial Information
Clinical Registry Describing Treatment Reality of Patients With Cancer-induced Anemia
Inclusion Criteria:
- histological verifiable tumor disease
- Hemoglobin level < standard value
- Antianemic therapy
- Performance status 0 - 3 (Karnofsky-Index >= 40%)
- Minimum age: 18 years
- Informed written consent
Exclusion Criteria:
- hypersensitivity against antianemic therapies
- Myelodysplastic Syndrome
- experimental antianemic therapy
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Documentation of therapies
Outcome Description:
Overview on the current routine treatment of anemia in cancer patients in Germany
Outcome Time Frame:
12 weeks per patient
Safety Issue:
No
Authority:
Germany: Ethics Commission
Study ID:
iOM TAn
NCT ID:
NCT01795690
Start Date:
December 2011
Completion Date:
Related Keywords:
- Anemia
- Anemia
- Cancer
- Hemoglobin
- Quality of Life
- FACT-An
- FACT-GP
- Erythropoiesis-Stimulating Agents (ESA)
- Epoetin
- Ferric Carboxymaltose
- Blood Transfusions
- Anemia
Name | Location |
|---|
